BioRestorative Therapies, Inc. Share Price
Stocks
BRTX
US0906557055
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
20:30:00 30/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 1.400 USD | -11.37% |
|
-13.56% | -94.04% |
| 10-09 | BioRestorative Therapies, Inc. Announces Board and Committee Changes | CI |
| 10-06 | Maxim Downgrades BioRestorative Therapies to Hold From Buy | MT |
| Market Cap | 1.78M 1.6M 1.47M 1.33M 2.49M 169M 2.54M 17.52M 7.03M 89.1M 6.69M 6.55M 281M | P/E 2026 * |
-0.11x | P/E 2027 * | -0.13x |
|---|---|---|---|---|---|
| Enterprise Value | 1.78M 1.6M 1.47M 1.33M 2.49M 169M 2.54M 17.52M 7.03M 89.1M 6.69M 6.55M 281M | EV / Sales 2026 * |
5.75x | EV / Sales 2027 * | 1.19x |
| Free-Float |
93.78% | Yield 2026 * |
-
| Yield 2027 * | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| BRTX | Delayed | |
Tradegate
| 9OF0 | Real-time | |
|
CBOE
| BRTX | Real-time | |
|
Deutsche Boerse AG
| 9OF0 | Delayed |
Last Transcript: BioRestorative Therapies, Inc.
| 1 day | -11.37% | ||
| 1 week | -13.56% | ||
| Current month | -39.90% | ||
| 1 month | -39.90% | ||
| 3 months | -68.95% | ||
| 6 months | -68.90% | ||
| Current year | -94.04% |
| 1 week | 1.36 |  | 1.65 |
| 1 month | 1.28 | | 2.43 |
| Current year | 1.28 | | 25.6 |
| 1 year | 1.28 | | 31 |
| 3 years | 1.28 | | 73.4 |
| 5 years | 1.28 | | 298.8 |
| 10 years | 1.28 | | 400,800 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mika Grasso
CEO | Chief Executive Officer | 28 | 26/08/2026 |
Anna Skowron
DFI | Director of Finance/CFO | 38 | 26/08/2026 |
Rory Rumore
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Mika Grasso
BRD | Director/Board Member | 28 | 11/06/2026 |
Jay Dhaliwal
BRD | Director/Board Member | 37 | 11/06/2026 |
Esha Randhawa
BRD | Director/Board Member | - | 12/07/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 06/10/25 | Free | Chief Technology Officer | 23,438 | 0.2938% | ||
| 06/10/25 | Free | Chief Executive Officer | 27,344 | 0.3427% | ||
| 14/02/25 | Other | Chief Technology Officer | 768,979 | 11.1125% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -11.37% | -13.56% | -95.36% | -96.29% | 1.78M | |
| -0.62% | -1.87% | +46.31% | +56.99% | 63.77B | |
| +0.35% | +3.20% | +14.92% | +84.55% | 56.37B | |
| +0.53% | +1.96% | +15.37% | +106.81% | 54.62B | |
| -2.81% | -4.31% | +23.50% | +50.90% | 44.06B | |
| -0.33% | -1.93% | +20.15% | +98.45% | 42.11B | |
| +0.55% | +2.31% | +224.97% | +942.56% | 41B | |
| +3.27% | +47.96% | +112.67% | +96.48% | 34.92B | |
| +1.22% | -1.44% | +14.89% | +47.15% | 32.82B | |
| +0.89% | +20.55% | -42.03% | +373.03% | 24.7B | |
| Average | -0.83% | +5.46% | +33.54% | +176.06% | 39.43B | |
| Weighted average by Cap. | +0.18% | +5.48% | +48.50% | +186.13% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 310K 278K 255K 231K 433K 29.43M 441K 3.05M 1.22M 15.48M 1.16M 1.14M 48.83M | 1.5M 1.34M 1.24M 1.12M 2.09M 142M 2.13M 14.74M 5.92M 74.92M 5.63M 5.51M 236M |
| Net income | -16.64M -14.9M -13.7M -12.42M -23.21M -1.58B -23.65M -163M -65.61M -831M -62.43M -61.11M -2.62B | -16.32M -14.62M -13.44M -12.18M -22.77M -1.55B -23.2M -160M -64.36M -815M -61.24M -59.94M -2.57B |
| Net Debt | - | - |
Employees
14
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/10/26 | US$1.400 | -11.37% | 28,799 |
| 29/10/26 | US$1.580 | +13.67% | 233,644 |
| 28/10/26 | US$1.390 | +2.21% | 17,910 |
| 27/10/26 | US$1.360 | -13.92% | 8,690 |
| 26/10/26 | US$1.580 | -2.47% | 35,010 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
1.400USD
Average target price
300.00USD
Spread / Average Target
+21,323.98%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BRTX Stock
Select your edition
All financial news and data tailored to specific country editions
